Oral glutamate loading in disorders with spinocerebellar and extrapyramidal involvement: effect on plasma glutamate, aspartate and taurine.
Altered metabolism of neuroexcitatory amino acids has been described in patients with a form of olivopontocerebellar atrophy (OPCA) associated with glutamate dehydrogenase (GDH) deficiency. To further investigate the specificity of these results, oral glutamate loading tests were performed in healthy controls, patients with GDH deficient OPCA as well as patients with non-GDH deficient degenerative disorders affecting primarily the function of the cerebellum and/or the basal ganglia. Following oral intake of monosodium glutamate, plasma levels of glutamate, aspartate and taurine increased significantly in controls and similar increases also occurred in patients with non-GDH deficient disorders. However, patients with GDH-deficient OPCA showed much greater elevations in plasma glutamate and aspartate and a rather flat taurine curve.
D001224:Aspartic Acid / Q000097:blood*; D001284:Atrophy; D001480:Basal Ganglia Diseases / Q000201:enzymology*; D002526:Cerebellar Diseases / Q000201:enzymology*; D002531:Cerebellum / Q000473:pathology; D005621:Friedreich Ataxia / Q000201:enzymology; D005969:Glutamate Dehydrogenase / Q000172:deficiency; D005971:Glutamates / Q000097:blood*; D018698:Glutamic Acid; D006801:Humans; D009410:Nerve Degeneration; D009847:Olivary Nucleus / Q000473:pathology; D010300:Parkinson Disease / Q000201:enzymology; D011149:Pons / Q000473:pathology; D012791:Shy-Drager Syndrome / Q000201:enzymology; D012970:Sodium Glutamate; D013118:Spinal Cord Diseases / Q000201:enzymology*; D013654:Taurine / Q000097:blood*
D005971:Glutamates; D013654:Taurine; D001224:Aspartic Acid; D018698:Glutamic Acid; D005969:Glutamate Dehydrogenase; D012970:Sodium Glutamate